Johnson and Johnson’s Covid-19 vaccine has another problematic rare side effect
As of 30 June, there have been 100 preliminary reports of Guillain-Barré syndrome in the US out of 12.8 million Johnson and Johnson vaccine doses given.
Business & Regulation
Setback of Seres’s late-stage candidate challenges microbiome space – register for free webinar
Join GlobalData on 10 August 2021 at 4pm BST for a free webinar giving an...
Chinese biosimilars surge between 2018 and 2020 due to new NMPA regulations
There has been an increase for China in biosimilar approvals and its biosimilars market will...
Social factors must be addressed to ensure the protection of community health
Healthcare payers and providers should consider social sustainability factors to ensure adequate community health protections...
Inside Philip Morris’ controversial Vectura acquisition
The tobacco company’s buyout of a healthcare business has sparked both fury and confusion from...
How is activity in the pharma sector recovering from Covid-19’s impact?
Analysis of jobs, deals, stock prices and financial filings and news sentiments now show pharma to be a relative winner when it comes to Covid-19 recovery.
Is the pharma sector seeing the beginnings of an AI investment boom?
AI deals, jobs and patents have been booming in the last few years. But is the pharma sector keeping up?
A new day for Alzheimer’s disease treatment after FDA approval of Biogen’s Aduhelm
The US Food and Drug Administration's (FDA) recent approval of Biogen's Aduhelm could signify a new era for the treatment of Alzheimer's disease.
Regenerative medicine: ready for the big leagues?
What is at the cutting-edge of regenerative medicine in 2021, and are these complex products ready to break into the big leagues?
IoT must become the Internet of Secure Things for widescale acceptance in the 5G era
2021 is seen as a year of catch-up for the Internet of Things. But IoT cyber security issues which dogged the tech in the 2010s continue to do so, Giacomo Lee explains.
